A fungal pathogen that infects both cats and humans is advancing northward through the Americas, prompting warnings from U.S. health authorities. Sporothrix brasiliensis, a dimorphic fungus native to Brazil, has expanded its geographic range dramatically over the past two decades, moving through Central America and into Mexico. CDC officials predict its arrival in the United States is inevitable.
The fungus causes sporotrichosis, a chronic infection affecting skin, lymph nodes, and occasionally the lungs. The disease typically enters through minor cuts or scratches, often from contaminated plant material or infected animals. Cats serve as amplifying hosts, developing severe skin lesions that shed high numbers of organisms, making feline-to-human transmission a particular concern. People handling infected cats face heightened exposure risk.
Sporothrix brasiliensis differs from the classical species, Sporothrix schenckii, which has circulated in temperate regions for decades. The Brazilian variant produces more aggressive infections with higher mortality rates in untreated cases. In endemic areas like Brazil, cat-associated sporotrichosis has become a public health issue, with hundreds of cases reported annually. Some regions document human infection rates exceeding those of animal bites.
The fungus adapts to warmer climates more readily than its predecessors, allowing expansion into previously unsuitable territories. Climate patterns and trade movements facilitate its spread, though the exact mechanisms of northward progression remain incompletely understood. Treatment with antifungal medications like itraconazole proves effective when diagnosed early, but delayed recognition complicates management.
CDC epidemiologists stress the need for laboratory capacity to distinguish Sporothrix brasiliensis from other Sporothrix species, as clinical presentations overlap. Veterinarians and dermatologists require heightened awareness to identify cases among cats and humans presenting with atypical skin lesions. Public